Federal Register / Vol. 74, No. 118 / Monday, June 22, 2009 / Notices 29499 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Community 

Conference. 

Date: July 16–17, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Michele C. HindiAlexander, PhD, Division of Scientific 

Review, National Institutes of Health, Eunice 

Kennedy Shriver National Institute of Child 

Health and Human Development, 6100 

Executive Boulevard, Rm. 5B01, Bethesda, 

MD 20892. (301) 435–8382. 

hindialm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: June 12, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–14509 Filed 6–19–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Grand 

Opportunities (GO) Grants in Human Cancer 

Proteomics. 

Date: July 21–22, 2009. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton at Old Town Alexandria, 

1767 King Street, Alexandria, VA 22314. 

Contact Person: Marvin L. Salin, PhD, 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 7073, 

Bethesda, MD 20892–8329, 301–496–0694, 

msalin@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control; 93.701, ARRA Related 

Biomedical Research and Research Support 

Awards, National Institutes of Health, HHS) 

Dated: June 12, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–14507 Filed 6–19–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Women’s 

Reproductive Health. 

Date: July 13, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Legacy Hotel, 1775 Rockville 

Pike, Rockville, MD 20852. 

Contact Person: Dennis E. Leszczynski, 

PhD, Scientific Review Administrator, 

Division of Scientific Review, National 

Institute of Child Health and Human 

Development, NIH, 6100 Executive Blvd., 

Rm. 5b01, Bethesda, MD 20892, (301) 435– 

6884, leszczyd@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: June 12, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–14505 Filed 6–19–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel. Arousal and 

Attention in High Risk Children. 

Date: July 14, 2009. 

Time: 1 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852. 

(Telephone Conference Call). 

Contact Person: Marita R. Hopmann, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, 6100 

Executive Boulevard, Room 5B01, Bethesda, 

MD 20892. (301) 435–6911. 

hopmannm@mail.nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel. Biobehavioral 

Foundations and Development of Cognitive 

Competence. 

Date: July 15, 2009. 

Time: 1 p.m. to 4:30 p.m. 


pwalker on PROD1PC71 with NOTICES
29500 Federal Register / Vol. 74, No. 118 / Monday, June 22, 2009 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852. 

(Telephone Conference Call). 

Contact Person: Marita R. Hopmann, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, 6100 

Executive Boulevard, Room 5B01, Bethesda, 

MD 20892. (301) 435–6911. 

hopmannm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: June 12, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–14503 Filed 6–19–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of the National Advisory 

Council for Healthcare Research and 

Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), Department of 

Health and Human Services. 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with section 

10(a) of the Federal Advisory Committee 

Act, 5 U.S.C. app. 2, this notice 

announces a meeting of the National 

Advisory Council for Healthcare 

Research and Quality. 

DATES: The meeting will be held on 

Friday, July 24, 2009, from 9 a.m. to 3 

p.m. 

ADDRESSES: The meeting will be held in 

Room 800, Hubert H. Humphrey 

Building, 200 Independence Avenue, 

SW., Washington, DC 20201. 

FOR FURTHER INFORMATION CONTACT: 

Deborah Queenan, Coordinator of the 

Advisory Council, at the Agency for 

Healthcare Research and Quality, 540 

Gaither Road, Rockville, Maryland 

20850, (301) 427–1330. For press-related 

information, please contact Karen 

Migdail at (301) 427–1855. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact Mr. 

Michael Chew, Director, Office of Equal 

Employment Opportunity Program, 

Program Support Center, on (301) 443– 

1144, no later than July 3, 2009. The 

agenda, roster, and minutes are 

available from Ms. Bonnie Campbell, 

Committee Management Officer, Agency 

for Healthcare Research and Quality, 

540 Gaither Road, Rockville, Maryland 

20850. Ms. Campbell’s phone number is 

(301) 427–1554. 

SUPPLEMENTARY INFORMATION: 

I. Purpose 

The National Advisory Council for 

Healthcare Research and Quality was 

established in accordance with section 

921 (now section 931) of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to actions of 

AHRQ to enhance the quality, improve 

the outcomes, and reduce the costs of 

health care services; improve access to 

such services through scientific 

research; and promote improvements in 

clinical practice and in the organization, 

financing, and delivery of health care 

services. 

The Council is composed of members 

of the public, appointed by the 

Secretary, and Federal ex-officio 

members. 

II. Agenda 

On Friday, July 24, the Council 

meeting will convene at 9 a.m., with the 

call to order by the Council Chair and 

approval of previous Council summary 

notes. The AHRQ director will present 

her update on current research, 

programs, and initiatives. The agenda 

will include a report from the 

subcommittee of Child Health Insurance 

Program Reauthorization Act (CHIPRA) 

Quality Provisions, a report on the 

National Quality and Disparities Reports 

(NHQR/NHDR) and a report on the 

recent Comparative Effectiveness 

Research Methods Symposium. 

The final agenda will be available on 

the AHRQ Web site at http:// 

www.ahrq.gov no later than July 20, 

2009. 

Dated: June 12, 2009. 

Carolyn M. Clancy, 

Director. 

[FR Doc. E9–14499 Filed 6–19–09; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

Coordinating Center for Health 

Promotion (BSC, CCHP) 

Place: CDC, Tom Harkins Global 

Communication Center, Auditorium B, 

Building 19, 1600 Clifton Road, NE., 

Atlanta, Georgia 30333. 

Correction: This notice was published 

in the Federal Register on June 11, 

2009, Volume 74, Number 111, Page 

27805. The location of the meeting has 

been changed. 

Late Statement: This notice is being 

published less than 15 days prior to the 

meeting due to programmatic issues that 

had to be resolved. 

Contact Person for More Information: 

Karen Steinberg, PhD, Senior Science 

Officer, Coordinating Center for Health 

Promotion, CDC, 4770 Buford Highway, 

NE., Mailstop E–70, Atlanta, Georgia 

30341; telephone (404) 498–6700; fax 

(404) 498–6880; e-mail 

karen.steinberg@cdc.gov. 

The Director, Management Analysis 

and Services Office has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both CDC and 

the Agency for Toxic Substances and 

Disease Registry. 

Dated: June 16, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–14544 Filed 6–19–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 


pwalker on PROD1PC71 with NOTICES